Literature DB >> 22679427

Multiple retroperitoneal schwannomas mimicking adrenal tumors.

Koichi Oishi1, Toshiyuki Itamoto, Sho Okimoto, Takashi Nishisaka.   

Abstract

Schwannomas are benign tumors mostly arising from the head and neck. Retroperitoneal schwannomas are rare. Here we report the case of a 68-year-old woman with multiple retroperitoneal schwannomas. An abdominal computed tomography (CT) scan showed 1 non-enhancing mass with a low-density area, 4.6 cm in diameter, in the left adrenal region and another non-enhancing mass with a low-density area, 2.9 cm in diameter, in the para-aortic region. The patient had regularly undergone CT scans for malignant tumor screening in maintenance dialysis patients. Retrospectively, the 2 tumors had existed in the same regions in previous CT scans and had gradually increased in size. The tumors were completely resected. Pathological diagnosis of both tumors was schwannoma. When a CT scan shows a slowly growing retroperitoneal tumor with a low-density area, schwannoma should be considered. If the tumor increases in size, complete resection should be performed for pathological diagnosis.

Entities:  

Keywords:  Adrenal tumor; Computed tomography scanning; Retroperitoneal schwannoma

Year:  2012        PMID: 22679427      PMCID: PMC3369249          DOI: 10.1159/000338973

Source DB:  PubMed          Journal:  Case Rep Oncol        ISSN: 1662-6575


Introduction

Schwannomas are benign tumors that arise from Schwann cells. These tumors are mostly found in the head and neck regions, and retroperitoneal schwannomas are rare. Multiple occurrences in the retroperitoneal region are extremely rare. We report on a 68-year-old woman with retroperitoneal schwannomas that were diagnosed by microscopic examination of surgically resected specimens, and we present a review of the literature on retroperitoneal schwannomas.

Case Report

A 68-year-old woman who had been receiving hemodialysis for chronic renal failure due to diabetic nephropathy was referred to our hospital for treatment of retroperitoneal tumors. The tumors were detected by one of the abdominal computed tomography (CT) scans that she had regularly undergone. She had been diagnosed with diabetes mellitus at the age of 46 years and had received hemodialysis 3 times a week since she was 59 years of age. She had no history of symptoms of von Recklinghausen disease. There was no family history of cancer. On physical examination at the time of consultation, her body temperature was 36.6°C, blood pressure was 164/80 mm Hg, and pulse rate was 67 beats/min and normal in rhythm. Her height was 160 cm and weight was 67 kg. Hematocrit was 29.7% and hemoglobin level was 9.8 g/dl. In renal function tests, blood urea nitrogen was 35.6 mg/dl and serum creatinine level was 7.16 mg/dl. Serum levels of sodium, potassium and chloride were 136, 6.0 and 101 mEq/l, respectively. Other results of complete blood count and liver function tests performed on admission were within normal ranges. Serum levels of adrenaline, noradrenaline, dopamine, cortisol and aldosterone were within normal ranges (24 pg/ml, 207 IU/l, 5 IU/l, 12.2 μg/dl and 94.1 pg/ml, respectively). Serum levels of carcinoembryonic antigen and carbohydrate antigen 19-9 were within normal ranges. An abdominal CT scan with administration of intravenous contrast material showed 1 non-enhancing mass with a low-density area, 4.6 cm in diameter, in the left adrenal region and another non-enhancing mass with a low-density area, 2.9 cm in diameter, in the para-aortic region (fig. ). The patient had been regularly examined by CT scan due to chronic renal failure. Retrospectively, the 2 tumors had never been pointed out by a physician but had existed in the same regions on a CT scan for 1 (fig. 1b, e) and 2 years (fig. 1c, f) before admission. The mean doubling times of the tumors in the left adrenal region and para-aortic region were 422 days and 270 days, respectively. The tumors had gradually increased in size on CT. Preoperative diagnosis was multiple pheochromocytomas or nonfunctioning adrenocortical carcinomas with lymph node metastasis, and she underwent an operation. On exploration of the intra-abdominal cavity, there were 2 tumors. One was in the para-aortic region and the other was in the left adrenal region. The tumor in the left adrenal region had compressed the left normal adrenal gland but was easily detached. Both tumors were completely excised and were diagnosed as schwannomas by microscopic examination of frozen sections.
Fig. 1

CT scan of the abdomen. CT scan of the abdomen with administration of intravenous contrast material showed 1 non-enhancing mass with a low-density area, 4.6 cm in diameter, in the left adrenal region (a) and another non-enhancing mass with a low-density area, 2.9 cm in diameter, in the para-aortic region (d). The 2 tumors could be seen in the same regions on CT scans performed 1 (b, e) and 2 years before (c, f). The tumors had gradually increased in size.

On gross examination, the tumor measuring 4.8 cm in diameter in the left adrenal region included yellow solid areas and cystic degeneration. The other tumor, 3.0 cm in diameter, in the para-aortic region included the same features (fig. ). Microscopic examination revealed that both tumors were composed of spindle cells with blunt nuclei in a fascicular pattern. Other regions in both tumors were composed of hypocellular spindle cells in a loose myxoid matrix. In immunohistochemical examination, spindle cells reacted to S-100 but did not react to anti-smooth-muscle actin. These findings corresponded to multiple schwannomas (fig. ). The patient was discharged 10 days after surgery and has had no recurrence in the 1 year since resection.

Discussion

Generally, schwannomas are benign tumors that develop from Schwann cells of the peripheral nerve sheath. These tumors occasionally occur in patients with von Recklinghausen disease. The most frequent sites are in the head and neck region. Retroperitoneal schwannomas are rare, accounting for only 1.2% of all retroperitoneal tumors [1]. The proportion of retroperitoneal schwannomas in all schwannomas has been reported to be 0.7–2.6% [2, 3]. Multiple retroperitoneal schwannomas are extremely rare. In our review of the English literature, we found only 3 reports of multiple retroperitoneal schwannomas [4-6]. Li et al. [6] reported 82 cases of retroperitoneal schwannomas, 2 of which were multiple schwannomas (2.4%). However, this statement about multiple schwannomas was the only information and there was no detailed information in their report about the age and sex of the patients, tumor size or location of the tumors. The other 2 reports were case reports. One was a report of a 47-year-old man with asynchronous tumors measuring 14, 16 and 10 cm [4]. The tumors histologically included low-grade sarcomatous change in a neurofibroma. The other was a report of a 49-year-old man with multiple retroperitoneal schwannomas [5]. However, 1 tumor was located in the paravertebral region at the T10 spinal level that was thought to be the posterior mediastinal region. Therefore, our patient is an extremely rare case of synchronous multiple schwannomas located in the retroperitoneal region and mimicking an adrenal tumor with lymph nodes metastasis. Schwannomas are generally solitary, well circumscribed and encapsulated [7]. Most patients are diagnosed at the age of 25–55 years, but schwannomas can occur at any age. There is no gender predilection. Most typical schwannomas grow slowly [8]. Moreover, clinical symptoms of retroperitoneal schwannomas appear later due to the anatomical position. When tumors are markedly increased in size, clinical symptoms of retroperitoneal schwannomas are initially noticed. Chief complaints of retroperitoneal schwannoma are often varied and nonspecific [7]. Some patients with retroperitoneal schwannomas present with vague, dull abdominal pain. Moreover, there are no distinctive findings to be noted in blood chemistry examination. Recently, with advances in imaging modalities, incidental detection of retroperitoneal tumors has been increasing, especially with increasing medical examination health screening. However, it is rare for retroperitoneal tumors to be preoperatively diagnosed as schwannomas. Small schwannomas appear as a homogenous, encapsulated mass, whereas large schwannomas show cystic degeneration, hemorrhage or central necrosis [9]. The most characteristic finding in schwannoma is cystic change. On CT scan with contrast enhancement, non-enhancing low-density areas in the tumor correspond to regions of cystic degeneration or necrotic regions [10]. In our case, retroperitoneal tumors were located in the left adrenal and para-aortic regions. We had preoperatively considered the tumors to be pheochromocytoma and paraganglioma or a nonfunctioning adrenal cancer with lymph node metastasis or malignant retroperitoneal tumors. CT imaging of typical adrenocortical carcinomas shows an inhomogeneous mass with heterogeneous enhancement of solid components [11]. Functional adrenocortical carcinomas are easily diagnosed by characteristic hormone-related symptoms or blood chemistry tests. However, nonfunctioning adrenocortical carcinomas that present no characteristic symptoms are difficult to diagnose by CT findings alone. Moreover, the tumor near the abdominal aorta was suspected to be lymph node metastasis from adrenocortical carcinoma. However, CT findings in our case were inconsistent with typical types of adrenocortical carcinomas. Additionally, nonfunctioning pheochromocytoma and paraganglioma were considered based on the location of the tumors. Characteristics of CT findings in typical pheochromocytomas are an inhomogeneous mass with relatively strong enhancement and a low-density area in tumors such as schwannomas [12]. Typical pheochromocytomas present characteristic clinical symptoms, whereas nonfunctioning pheochromocytomas commonly present no characteristic symptoms. Therefore, Inokuchi et al. [13] reported that it is difficult to differentiate between retroperitoneal schwannomas and nonfunctioning pheochromocytomas by imaging. Consequently, a definite diagnosis can only be made histologically. The location of tumors and the existence of multiple tumors in our case made diagnosis difficult. However, CT imaging in the patient showed a low-density area in the tumor, retrospectively. Moreover, comparison with previous CT scans performed 1 and 2 years before showed that the tumors had been gradually increasing in size. Tumor doubling time was calculated by comparison with previous CT scans. Doubling times of most malignant tumors are less than 6 month [14]. There have been no reports on tumor doubling times of retroperitoneal schwannomas. However, tumor doubling times of vestibular schwannomas have been reported to be over 1 year [15]. Tumor doubling times in our patient were about 1 year. These findings were consistent with the characteristics of schwannomas, i.e. slow tumor growth and having cystic change. Additionally, a case of schwannoma in which a long-term course is observed is extremely rare. In summary, we have reported a case of multiple retroperitoneal schwannomas. When a CT scan shows a slowly growing retroperitoneal tumor with a low-density area, schwannoma should be considered. If a retroperitoneal tumor is considered to be schwannoma, the patient should be carefully followed up. If the tumor gradually increases in size or clinical symptoms appear, complete surgical resection should be performed for pathological diagnosis.

Disclosure Statement

The authors have no conflicts of interest to declare.
  15 in total

Review 1.  On the growth rates of human malignant tumors: implications for medical decision making.

Authors:  S Friberg; S Mattson
Journal:  J Surg Oncol       Date:  1997-08       Impact factor: 3.454

2.  Primary retroperitoneal tumors.

Authors:  D B SCANLAN
Journal:  J Urol       Date:  1959-06       Impact factor: 7.450

Review 3.  Integrated imaging of adrenal disease.

Authors:  I R Francis; M D Gross; B Shapiro; M Korobkin; L E Quint
Journal:  Radiology       Date:  1992-07       Impact factor: 11.105

4.  CT features of retroperitoneal neurilemmoma.

Authors:  T Kinoshita; H Naganuma; K Ishii; H Itoh
Journal:  Eur J Radiol       Date:  1998-03       Impact factor: 3.528

5.  Benign encapsulated neurilemoma: a report of 76 cases.

Authors:  W G Whitaker; C Droulias
Journal:  Am Surg       Date:  1976-09       Impact factor: 0.688

6.  Is clinical growth index a reliable predictor of tumour growth in vestibular schwannomas?

Authors:  A Mohyuddin; E A Vokurka; D G R Evans; R T Ramsden; A Jackson
Journal:  Clin Otolaryngol Allied Sci       Date:  2003-04

7.  Multiple primary retroperitoneal tumours: a unique case.

Authors:  J J Patel; I Taylor; S Fleming
Journal:  Br J Surg       Date:  1989-08       Impact factor: 6.939

8.  Retroperitoneal schwannoma.

Authors:  Brian K P Goh; Yu-Meng Tan; Yaw-Fui A Chung; Pierce K H Chow; London L P J Ooi; Wai-Keong Wong
Journal:  Am J Surg       Date:  2006-07       Impact factor: 2.565

9.  Benign solitary Schwannomas (neurilemomas).

Authors:  T K Das Gupta; R D Brasfield; E W Strong; S I Hajdu
Journal:  Cancer       Date:  1969-08       Impact factor: 6.860

10.  Retroperitoneal neurilemoma: CT and MR findings.

Authors:  S H Kim; B I Choi; M C Han; Y I Kim
Journal:  AJR Am J Roentgenol       Date:  1992-11       Impact factor: 3.959

View more
  3 in total

1.  Unusual presentation of retroperitoneal Schwannoma: case report.

Authors:  R Latino; Daniela Bosco; M E Frattallone; A Amico; R Lanteri; A Di Cataldo
Journal:  G Chir       Date:  2017 Nov-Dec

Review 2.  Retroperitoneal schwannomas: dilemmas in diagnostic approach and therapeutic management.

Authors:  Aikaterini Mastoraki; Felicia Toska; Ioannis Tsiverdis; Maria Kyriazi; Athanasios Tsagkas; Nikolaos Danias; Vasilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  J Gastrointest Cancer       Date:  2013-12

3.  Surgical management of retroperitoneal schwannoma complicated with severe hydronephrosis: A case report.

Authors:  Liandong Zhang; Ming Gao; Tongdian Zhang; Tie Chong; Ziming Wang; Wenpin Liu; Hecheng Li
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.